Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Matthew Hirschtritt

    TitleResident Physician
    SchoolUCSF School of Medicine
    DepartmentPsychiatry
    Address401 Parnassus Ave.
    San Francisco CA 94143
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Hirschtritt ME, Dy ME, Yang KG, Scharf JM. Child Neurology: Diagnosis and treatment of Tourette syndrome. Neurology. 2016 Aug 16; 87(7):e65-7. PMID: 27527544.
        View in: PubMed
      2. Hirschtritt ME, Besterman AD, Ross DA. Psychiatric Pharmacogenomics: How Close Are We? Biol Psychiatry. 2016 Oct 15; 80(8):e63-5. PMID: 27663067.
        View in: PubMed
      3. Hirschtritt ME, Darrow SM, Illmann C, Osiecki L, Grados M, Sandor P, Dion Y, King RA, Pauls DL, Budman CL, Cath DC, Greenberg E, Lyon GJ, Yu D, McGrath LM, McMahon WM, Lee PC, Delucchi KL, Scharf JM, Mathews CA. Social disinhibition is a heritable subphenotype of tics in Tourette syndrome. Neurology. 2016 Aug 2; 87(5):497-504. PMID: 27371487.
        View in: PubMed
      4. Hirschtritt ME, Ordóñez AE, Rico YC, LeWinn KZ. Internal resilience, peer victimization, and suicidal ideation among adolescents. Int J Adolesc Med Health. 2015 Nov 1; 27(4):415-23. PMID: 25719294.
        View in: PubMed
      5. Hirschtritt ME, Lee PC, Pauls DL, Dion Y, Grados MA, Illmann C, King RA, Sandor P, McMahon WM, Lyon GJ, Cath DC, Kurlan R, Robertson MM, Osiecki L, Scharf JM, Mathews CA. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry. 2015 Apr; 72(4):325-33. PMID: 25671412; PMCID: PMC4446055.
      6. Peachey NS, Pearring JN, Bojang P, Hirschtritt ME, Sturgill-Short G, Ray TA, Furukawa T, Koike C, Goldberg AF, Shen Y, McCall MA, Nawy S, Nishina PM, Gregg RG. Depolarizing bipolar cell dysfunction due to a Trpm1 point mutation. J Neurophysiol. 2012 Nov; 108(9):2442-51. PMID: 22896717; PMCID: PMC3545183.
      7. Hirschtritt ME, Pagano ME, Christian KM, McNamara NK, Stansbrey RJ, Lingler J, Faber JE, Demeter CA, Bedoya D, Findling RL. Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders. J Subst Abuse Treat. 2012 Jun; 42(4):366-72. PMID: 22116008; PMCID: PMC3415216.
      8. Kiringoda R, Thurm AE, Hirschtritt ME, Koziol D, Wesley R, Swedo SE, O'Grady NP, Quezado ZM. Risks of propofol sedation/anesthesia for imaging studies in pediatric research: eight years of experience in a clinical research center. Arch Pediatr Adolesc Med. 2010 Jun; 164(6):554-60. PMID: 20530306; PMCID: PMC3197223.
      9. Hirschtritt ME, Hammond CJ, Luckenbaugh D, Buhle J, Thurm AE, Casey BJ, Swedo SE. Executive and attention functioning among children in the PANDAS subgroup. Child Neuropsychol. 2009 Mar; 15(2):179-94. PMID: 18622810; PMCID: PMC2693234.
      10. Grant P, Lougee L, Hirschtritt M, Swedo SE. An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. J Child Adolesc Psychopharmacol. 2007 Dec; 17(6):761-7. PMID: 18315448.
        View in: PubMed
      Matthew's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP